Tilbage til Business Angel & Bestyrelser
CytoVac A/S is a biotechnology company that is developing a new method for treatment of cancer.
A treatment method that is based on the patient’s own immune system. This treatment method is called ALECSAT therapy and is based on enabling the patient’s own immune system to fight the cancer.
Applying the ALECSAT method, one can, from a blood donation from the patient, isolate, activate and cultivate specific cells from the immune system outside the patient’s body. These cells are then delivered back to cancer patient where they attack cancer cells and enhance the patient’s immune system in the battle against cancer.